Profile	GDS3514 / 213374_x_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	688.888	64
GSM325241	Patient no. 1: treated	416.805	54
GSM325242	Patient no. 9: control	344.508	52
GSM325243	Patient no. 9: treated	297.39	48
GSM325244	Patient no. 18: control	939.001	72
GSM325245	Patient no. 18: treated	818.302	69
GSM325246	Patient no. 12: control	254.542	48
GSM325247	Patient no. 12: treated	335.339	55
GSM325248	Patient no. 3: control	1420	79
GSM325249	Patient no. 3: treated	1431.22	79
GSM325250	Patient no. 7: control	525.841	63
GSM325251	Patient no. 7: treated	775.32	71
GSM325252	Patient no. 15: control	987.598	73
GSM325253	Patient no. 15: treated	1279.69	78
GSM325254	Patient no. 4: control	1613.47	82
GSM325255	Patient no. 4: treated	1294.67	78
GSM325256	Patient no. 19: control	220.073	43
GSM325257	Patient no. 19: treated	146.606	37
GSM325258	Patient no. 14: control	788.058	69
GSM325259	Patient no. 14: treated	719.382	66
GSM325260	Patient no. 13: control	990.816	73
GSM325261	Patient no. 13: treated	1242.48	77
GSM325262	Patient no. 17: control	816.918	68
GSM325263	Patient no. 17: treated	580.536	61
GSM325264	Patient no. 10: control	487.911	59
GSM325265	Patient no. 10: treated	349.693	51
GSM325266	Patient no. 5: control	721.944	66
GSM325267	Patient no. 5: treated	300.564	54
GSM325268	Patient no. 11: control	856.957	69
GSM325269	Patient no. 11: treated	429.575	58
GSM325270	Patient no. 6: control	2091.28	86
GSM325271	Patient no. 6: treated	1152.94	78
GSM325272	Patient no. 8: control	2314	87
GSM325273	Patient no. 8: treated	634.085	64
GSM325274	Patient no. 16: control	1116.41	75
GSM325275	Patient no. 16: treated	302.864	50
GSM325276	Patient no. 2: control	1732.17	82
GSM325277	Patient no. 2: treated	645.239	67